510(k) Report

510(k) · Cleared

Cleared

Visionsearch 1

K120104510(k) TraditionalCleared May 21, 2012129-day reviewClass II21 CFR 882.1890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Visionsearch Pty, Ltd. · GWE Stimulator, Photic, Evoked Response

Cleared on May 21, 2012 as substantially equivalent to K023525 (Roland Consult, 2004) after a 129-day review. Its family tree reaches back 2 generations to 1986.

Decided
May 21, 2012
Review
129 days
Class
Class II
Product code
GWE
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K863956 (1986). 3 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2001: 1 other ancestorK863956 · Maculoscope (TM) · Doran Instruments, Inc. · 1986K023525 · Retiscan, Retiport · Roland Consult · 2004198519901995200020052010
Other ancestors, by generation 2 generations back: 1 other ancestor K023525 · Retiscan, Retiport · Roland Consult · 2004K863956 · Maculoscope (TM) · Doran Instruments, Inc. · 19860
  1. Root · 2 generations backK863956 Maculoscope (TM)Doran Instruments, Inc. · 1986
  2. 1 generation backK023525 Retiscan, RetiportRoland Consult · 2004
  3. This deviceK120104 Visionsearch 1Visionsearch Pty, Ltd. · 2012
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K863956Maculoscope (TM)Doran Instruments, Inc.1986—
−1K023525Retiscan, RetiportRoland Consult2004—
0 (this device)K120104Visionsearch 1Visionsearch Pty, Ltd.2012—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
FIG. 1 — Lineage of K120104, 1986–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GWE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GWE device

  1. #1 K211643 Vision Monitor - MonpackONEscore 5.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K023525Retiscan, Retiport
Summary page 2
…g the same intended use and technological characteristics as summarized in the following Comparison Table. Feature Predicate RETIscan (K023525) Visionsearchi Generate photic signals and measure intended use…
Roland Consult2004—

Also cleared against K023525: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 3 companies; a new generation was cleared every 17.4 years on median.
  • None of the 3 ancestors has a recall.
  • 3 other devices also cite its predicate K023525.

How does its category compare?

All GWE devices

GWE Stimulator, Photic, Evoked Response: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · GWE

2in 2022

2009: 12010: 12011: 12012: 22015: 12018: 12020: 12021: 22022: 2
2007high 2 (2012) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GWE

Too few GWE 510(k)s in any year since 2007 to give a median.

Recalls per year · GWE

1in 2015

2007: 12015: 1
2007high 1 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GWE

1in 2025

2008: 12010: 12012: 12014: 12016: 22018: 22022: 22025: 1
2007high 2 (2016) · low 0 (2007)2025

MAUDE reports naming product code GWE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—10
20080—01
20091—00
20101—01
20111—00
20122—01
20130—00
20140—01
20151—10
20160—02
20170—00
20181—02
20190—00
20201—00
20212—00
20222—02
20230—00
20240—00
20250—01
20260—0—

What is it indicated for?

Electrophysiologictal Test Unit for quantifying the response

to visual stimulation by measuring the Visual Evoked Potential.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K120104: Visionsearch 1.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K120104

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026